BioNTech SE – ADR (NASDAQ: BNTX) reported upbeat fourth-quarter financial results and issued FY26 sales guidance below estimates on Tuesday. BioNTech reported quarterly losses of 38 cents per share ...

BioNTech’sBNTX4.26%increase; green up pointing triangle co-founders, the husband-and-wife team who helped bring the first Covid-19 vaccine to the market during the depths of the pandemic, are leaving ...

German biopharma outfit BioNTech SE reported lackluster fiscal Q4 results on Tuesday. Guidance for the year now underway is just as disappointing. The creators of this company’s breakthrough science ...

The founders of the biotech company that developed Comirnaty, the mRNA-based COVID-19 vaccine sold by BioNTech and Pfizer, will step down and form a new mRNA company. BioNTech said Tuesday that Ugur ...

BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanning immunomodulator, ADC and mRNA candidates BioNTech co-founders Ugur Sahin and Özlem Türeci will ...

BioNTech’s CEO and his fellow co-founder will depart the biopharma by the end of the year to head up a new company focused on “next generation mRNA innovations.” Uğur Şahin, M.D., who is currently the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — The co-founders of the Covid-19 vaccine developer BioNTech plan ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's ‌COVID-19 shot mNEXSPIKE infringes a patent related to COVID ...

BioNTech SE (NASDAQ:BNTX) is one of the best stocks to buy and hold for the next 6 months. On February 2, research firm Leerink Partners downgraded BioNTech SE (NASDAQ:BNTX) to a Market Perform from ...

An update from BioNTech SE ( (BNTX)) is now available. On January 6, 2026, BioNTech SE reported that CureVac N.V. had completed a previously announced post-offer reorganization related to BioNTech’s ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) announced the closing of its acquisition of CureVac N.V. (NASDAQ:CVAC), which ...

BioNTech SE shared its Q3 earnings, business updates, and guidance for 2025 earlier today. Its share price is down 1% in trading so far. BNTX maintains a strong cash position, driven by ongoing ...